Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike

增强可溶性 HIV-1 包膜三聚体的聚糖占据率,以模拟天然病毒刺突蛋白。

阅读:4
作者:Ronald Derking ,Joel D Allen ,Christopher A Cottrell ,Kwinten Sliepen ,Gemma E Seabright ,Wen-Hsin Lee ,Yoann Aldon ,Kimmo Rantalainen ,Aleksandar Antanasijevic ,Jeffrey Copps ,Anila Yasmeen ,Albert Cupo ,Victor M Cruz Portillo ,Meliawati Poniman ,Niki Bol ,Patricia van der Woude ,Steven W de Taeye ,Tom L G M van den Kerkhof ,P J Klasse ,Gabriel Ozorowski ,Marit J van Gils ,John P Moore ,Andrew B Ward ,Max Crispin ,Rogier W Sanders

Abstract

Artificial glycan holes on recombinant Env-based vaccines occur when a potential N-linked glycosylation site (PNGS) is under-occupied, but not on their viral counterparts. Native-like SOSIP trimers, including clinical candidates, contain such holes in the glycan shield that induce strain-specific neutralizing antibodies (NAbs) or non-NAbs. To eliminate glycan holes and mimic the glycosylation of native BG505 Env, we replace all 12 NxS sequons on BG505 SOSIP with NxT. All PNGS, except N133 and N160, are nearly fully occupied. Occupancy of the N133 site is increased by changing N133 to NxS, whereas occupancy of the N160 site is restored by reverting the nearby N156 sequon to NxS. Hence, PNGS in close proximity, such as in the N133-N137 and N156-N160 pairs, affect each other's occupancy. We further apply this approach to improve the occupancy of several Env strains. Increasing glycan occupancy should reduce off-target immune responses to vaccine antigens. Keywords: HIV-1 vaccine research; cryo-EM; glycan occupancy; mass spectrometry.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。